ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 233 filers reported holding ROYALTY PHARMA PLC in Q2 2021. The put-call ratio across all filers is 1.38 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,617,741 | +10.1% | 501,864 | +24.7% | 0.00% | 0.0% |
| Q2 2023 | $12,373,030 | -12.0% | 402,547 | +3.2% | 0.00% | -20.0% |
| Q1 2023 | $14,052,357 | +109273.9% | 389,959 | +20.0% | 0.01% | +25.0% |
| Q4 2022 | $12,848 | -99.9% | 325,077 | -3.1% | 0.00% | -20.0% |
| Q3 2022 | $13,479,000 | +9.4% | 335,439 | +14.5% | 0.01% | +25.0% |
| Q2 2022 | $12,316,000 | +10.9% | 292,960 | +2.8% | 0.00% | +33.3% |
| Q1 2022 | $11,102,000 | +21.0% | 284,941 | +23.8% | 0.00% | 0.0% |
| Q4 2021 | $9,174,000 | +58.1% | 230,201 | +43.4% | 0.00% | +50.0% |
| Q3 2021 | $5,803,000 | +1447.5% | 160,515 | +1655.0% | 0.00% | – |
| Q2 2021 | $375,000 | -9.2% | 9,146 | -3.1% | 0.00% | – |
| Q1 2021 | $413,000 | – | 9,441 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |